Browse by Uncontrolled Keywords
Number of items: 17.
2014
Lazarus, JV;
Lundgren, J;
Casabona, J;
Wiessing, L;
Matheï, C;
Vickerman, P;
Prins, M;
Kretzschmar, M;
Kantzanou, M;
Giraudon, I;
+10 more...
Ferri, M;
Griffiths, P;
Harris, M;
Walker, M;
Chavdarova, L;
Schatz, E;
Schiffer, K;
Kools, JP;
Farell, J;
Mendão, L;
(2014)
Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis.
BMC infectious diseases, 14 (Suppl).
S18-S18.
ISSN 1471-2334
DOI: https://doi.org/10.1186/1471-2334-14-S6-S18
2011
Schmidt, AJ;
Rockstroh, JK;
Vogel, M;
An der Heiden, M;
Baillot, A;
Krznaric, I;
Radun, D;
(2011)
Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study.
PloS one, 6 (3).
e17781.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0017781
2008
Nascimento, MC;
Mayaud, P;
Sabino, EC;
Torres, KL;
Franceschi, S;
(2008)
Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: A multi-center serosurvey.
Journal of medical virology, 80 (1).
pp. 53-57.
ISSN 0146-6615
DOI: https://doi.org/10.1002/jmv.21046
Full text not available from this repository.
Ruf, M;
Cohuet, S;
Maguire, H;
Brant, LJ;
Ramsay, M;
Lattimore, S;
Delpech, V;
SNAHC Steering Group;
(2008)
Situation of HIV infections and STIs in the United Kingdom in 2007.
Euro surveillance, 13 (47).
ISSN 1025-496X
https://researchonline.lshtm.ac.uk/id/eprint/2319288
Thomson, BJ;
Kwong, G;
Ratib, S;
Sweeting, M;
Ryder, SD;
de Angelis, D;
Grieve, R;
Irving, WL;
(2008)
Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management.
Journal of viral hepatitis, 15 (4).
pp. 271-278.
ISSN 1352-0504
DOI: https://doi.org/10.1111/j.1365-2893.2007.00941.x
Full text not available from this repository.
2007
Mateu-Gelabert, P;
Treloar, C;
Calatayud, VA;
Sandoval, M;
Zurian, JCV;
Maher, L;
Rhodes, T;
Friedman, SR;
(2007)
How can hepatitis C be prevented in the long term?
The International journal on drug policy, 18 (5).
pp. 338-340.
ISSN 0955-3959
DOI: https://doi.org/10.1016/j.drugpo.2007.06.001
Full text not available from this repository.
Rozman, MA;
Alves, IS;
Porto, MA;
Gomes, PO;
Ribeiro, NM;
Nogueira, LAA;
Caseiro, MM;
da Silva, VA;
Massad, E;
Burattini, MN;
(2007)
HIV and related infections in a sample of recyclable waste collectors of Brazil.
International journal of STD & AIDS, 18 (9).
pp. 653-654.
ISSN 0956-4624
DOI: https://doi.org/10.1258/095646207781568574
Full text not available from this repository.
Sweeting, MJ;
de Angelis, D;
Brant, LJ;
Harris, HE;
Mann, AG;
Ramsay, ME;
(2007)
The burden of hepatitis C in England.
Journal of viral hepatitis, 14 (8).
pp. 570-576.
ISSN 1352-0504
DOI: https://doi.org/10.1111/j.1365-2893.2007.00851.x
Full text not available from this repository.
2006
Sutton, AJ;
Edmunds, WJ;
Gill, ON;
(2006)
Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison.
BMC public health, 6.
p. 170.
ISSN 1471-2458
DOI: https://doi.org/10.1186/1471-2458-6-170
2005
Judd, A;
Hickman, M;
Jones, S;
McDonald, T;
Parry, JV;
Stimson, GV;
Hall, AJ;
(2005)
Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study.
BMJ.
p. 24.
ISSN 1468-5833
DOI: https://doi.org/10.1136/bmj.38286.841227.7C
2004
Kirk, GD;
Lesi, OA;
Mendy, M;
Akano, AO;
Sam, O;
Goedert, JJ;
Hainaut, P;
Hall, AJ;
Whittle, H;
Montesano, R;
(2004)
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
Hepatology (Baltimore, Md), 39 (1).
p. 211.
ISSN 0270-9139
DOI: https://doi.org/10.1002/hep.20027
Full text not available from this repository.
2003
Hall, AJ;
Wild, CP;
(2003)
Liver cancer in low and middle income countries - Prevention should target vaccination, contaminated needles, and aflatoxins.
BMJ (Clinical research ed), 326 (7397).
pp. 994-995.
ISSN 0959-8138
DOI: https://doi.org/10.1136/bmj.326.7397.994
Yee, LJ;
Perez, KA;
Tang, J;
van Leeuwen, DJ;
Kaslow, RA;
(2003)
Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection.
The Journal of infectious diseases, 187 (8).
pp. 1264-71.
ISSN 0022-1899
DOI: https://doi.org/10.1086/374561
Full text not available from this repository.
2002
Fillon, S;
Klingel, K;
Warntges, S;
Sauter, M;
Gabrysch, S;
Pestel, S;
Tanneur, V;
Waldegger, S;
Zipfel, A;
Viebahn, R;
+4 more...
Haussinger, D;
Broer, S;
Kandolf, R;
Lang, F;
(2002)
Expression of the serine/threonine kinase hSGK1 in chronic viral hepatitis.
Cellular physiology and biochemistry, 12 (1).
pp. 47-54.
ISSN 1015-8987
DOI: https://doi.org/10.1159/000047826
Full text not available from this repository.
Grieve, R;
Roberts, J;
(2002)
Economic evaluation for hepatitis C.
Acta gastro-enterologica Belgica, 65 (2).
pp. 104-9.
ISSN 0001-5644
https://researchonline.lshtm.ac.uk/id/eprint/17441
Full text not available from this repository.
van Leeuwen, DJ;
Yee, LJ;
Langner, RG;
(2002)
24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients.
The American journal of gastroenterology, 97 (2).
pp. 497-8.
ISSN 0002-9270
DOI: https://doi.org/10.1016/S0002-9270(01)04074-6
Full text not available from this repository.
2001
Rhodes, SD;
Diclemente, RJ;
Yee, LJ;
Hergenrather, KC;
(2001)
Factors associated with testing for hepatitis C in an internet-recruited sample of men who have sex with men.
Sexually transmitted diseases, 28 (9).
pp. 515-20.
ISSN 0148-5717
DOI: https://doi.org/10.1097/00007435-200109000-00007
Full text not available from this repository.